Rosuva 10 Tablet
by Square Pharmaceuticals Limited
৳22.00
Ziska Pharmaceuticals Limited
Rosuvastatin
Heterozygous Hypercholesterolemia (Familial and Non familial)
Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methyl glutaryl coenzyme A to mevalonate, a precursor of cholesterol.
Rosuvastatin can be taken with or without food, at any time of day.
Combination increases Rosuvastatin exposure. Rosuvastatin dose should be limited to 5 mg once daily.
Known hypersensitivity to product components
Liver disease, which may include unexplained persistent elevations in hepatic transaminase levels
Pregnant women and women who may become pregnant.
Rosuvastatin is generally well tolerated. The most frequent adverse events thought to be related to Rosuvastatin were headache, myalgia, constipation, asthenia, abdominal pain and nausea.
The safety in pregnant women has not been established. It is not known whether Rosuvastatin is excreted in human milk or not.
isks increase with use of 40 mg dose, advanced age (>65 year), hypothyroidism, renal impairment and combination use with cyclosporine, lopinavir/ritonavir, atazanavir/ritonavir or certain other lipid-lowering drugs.
Other Anti-anginal & Anti-ischaemic drugs, Statins
Keep below 30oC temperature, protected from light & moisture. Keep out of the reach of children.
Ziska Pharmaceuticals Ltd.